Abstract
In this article, we report on a case of a pregnant patient with synchronous bilateral breast cancer treated with weekly paclitaxel. She presented after right mastectomy and anthracycline-based chemotherapy at an outside facility. Staging studies at our hospital before taxane administration demonstrated a 19-20-week gravid uterus and tumor in the remaining left breast. Weekly paclitaxel was given preoperatively during pregnancy. A normal male infant was delivered. Upon completion of chemotherapy, the patient underwent mastectomy and axillary lymph node dissection followed by comprehensive radiation therapy to the chest wall.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Adult
-
Antineoplastic Agents, Phytogenic / administration & dosage
-
Antineoplastic Agents, Phytogenic / therapeutic use*
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / metabolism
-
Breast Neoplasms / pathology
-
Female
-
Humans
-
Neoplasm Staging
-
Paclitaxel / administration & dosage
-
Paclitaxel / therapeutic use*
-
Pregnancy
-
Pregnancy Outcome
-
Receptors, Estrogen / metabolism
-
Receptors, Progesterone / metabolism
-
Tamoxifen / administration & dosage
-
Tamoxifen / therapeutic use
-
Treatment Outcome
Substances
-
Antineoplastic Agents, Phytogenic
-
Receptors, Estrogen
-
Receptors, Progesterone
-
Tamoxifen
-
Paclitaxel